Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial

This publication has 22 references indexed in Scilit:

• The on- and off-target effects of morphine in acute coronary syndrome: A narrative review
  American Heart Journal, 2016
• P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction
  Thrombosis and Haemostasis, 2016
• Correlates of pre-hospital morphine use in ST-elevation myocardial infarction patients and its association with in-hospital outcomes and long-term mortality: the FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) programme
  European Heart Journal, 2015
• Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial
  European Heart Journal, 2015
• Intravenous morphine administration and reperfusion success in ST-elevation myocardial infarction: insights from cardiac magnetic resonance imaging
  Clinical Research in Cardiology, 2015
• Ticagrelor Crushed Tablets Administration in STEMI Patients
  JACC, 2015
• Morphine Is Associated With a Delayed Activity of Oral Antiplatelet Agents in Patients With ST-Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
  Circulation: Cardiovascular Interventions, 2015
• Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction
  New England Journal of Medicine, 2014
• Morphine Decreases Clopidogrel Concentrations and Effects
  JACC, 2014
• Association of intravenous morphine use and outcomes in acute coronary syndromes: Results from the CRUSADE Quality Improvement Initiative
  American Heart Journal, 2005